Staging system for mycosis fungoides
Stage . | Tumor . | Lymph node . | Metastasis . |
---|---|---|---|
IA | T1 | N0 | M0 |
IB | T2 | N0 | M0 |
IIA | T1 or T2 | N1 | M0 |
IIB | T3 | N0 or N1 | M0 |
III | T4 | N0 or N1 | M0 |
IVA | T1-T4 | N2 or N3 | M0 |
IVB | T1-T4 | N0-N3 | M1 |
Stage . | Tumor . | Lymph node . | Metastasis . |
---|---|---|---|
IA | T1 | N0 | M0 |
IB | T2 | N0 | M0 |
IIA | T1 or T2 | N1 | M0 |
IIB | T3 | N0 or N1 | M0 |
III | T4 | N0 or N1 | M0 |
IVA | T1-T4 | N2 or N3 | M0 |
IVB | T1-T4 | N0-N3 | M1 |
The staging system for mycosis fungoides was devised by Bunn and Lamberg in 1979.2
T indicates tumor; T1, patches or plaques over less than 10% of the body surface; T2, patches or plaques over more than 10% of the body surface; T3, more than one tumor; T4, erythroderma; N, lymph node; N0, no palpable lymphadenopathy or histological evidence of mycosis fungoides; N1, palpable node, no histological evidence of mycosis fungoides; N2, no palpable nodes, but histological evidence of mycosis fungoides; N3, palpable nodes and histological evidence of mycosis fungoides; M, metastasis; M0, no visceral involvement; M1, histologically confirmed visceral involvement.